Standard Family Office’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
Standard Family Office's DGX Position: Q3 2021 in Review
Standard Family Office sold out of Quest Diagnostics (DGX) in Q3 2021, closing a stake of 8 shares — an estimated $1K sold.
Standard Family Office first reported a position in DGX in Q1 2021 and held it in 2 quarters. The position peaked at $1K in Q2 2021. 837 funds tracked by Wall St. Rank hold DGX as of Q3 2021.
- Standard Family Office reported no remaining Quest Diagnostics position as of Q3 2021 after selling out during the quarter.
- Standard Family Office sold 8 Quest Diagnostics shares in Q3 2021, an estimated $1K.
- Standard Family Office first reported a position in Quest Diagnostics in Q1 2021 and held it in 2 quarters.
- Standard Family Office's Quest Diagnostics position peaked at $1K in Q2 2021.
- 837 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.
Based on Standard Family Office's 13F filing for Q3 2021, filed 15 Nov 2021.